INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 319 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,162,256 | +48.0% | 36,757 | +90.9% | 0.00% | – |
| Q2 2023 | $785,300 | +8.0% | 19,257 | -1.3% | 0.00% | – |
| Q1 2023 | $726,802 | +12.4% | 19,501 | +5.2% | 0.00% | – |
| Q4 2022 | $646,651 | -44.9% | 18,534 | -11.5% | 0.00% | -100.0% |
| Q3 2022 | $1,173,000 | +6.2% | 20,954 | -1.7% | 0.00% | 0.0% |
| Q2 2022 | $1,104,000 | -29.5% | 21,320 | -1.1% | 0.00% | 0.0% |
| Q1 2022 | $1,566,000 | -47.5% | 21,556 | -14.6% | 0.00% | 0.0% |
| Q4 2021 | $2,983,000 | +0.8% | 25,232 | +14.4% | 0.00% | -50.0% |
| Q3 2021 | $2,958,000 | -14.2% | 22,051 | +3.6% | 0.00% | 0.0% |
| Q2 2021 | $3,446,000 | +89.7% | 21,282 | -6.0% | 0.00% | +100.0% |
| Q1 2021 | $1,817,000 | +116.6% | 22,641 | +46.8% | 0.00% | 0.0% |
| Q4 2020 | $839,000 | – | 15,428 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
| Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
| MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
| ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
| Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
| Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
| Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
| Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
| Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |